Overview of INVIMA and Its Role in Pharmaceutical Regulation – drug regulatory affairs Overview of INVIMA and Its Role in Pharmaceutical Regulation In the rapidly evolving landscape of global pharmaceutical development, understanding the role of drug regulatory authorities is crucial. In Colombia, the National Institute for Food and Drug Surveillance (INVIMA) serves as the primary regulatory body overseeing the approval and regulation of pharmaceuticals. This article provides a comprehensive step-by-step guide on navigating the regulatory landscape in Colombia, focusing on INVIMA’s processes and requirements for pharmaceutical drug regulatory affairs. It outlines dossier structure, good manufacturing practices (GMP), pharmacovigilance, and approval…

Marketing Authorization Process for Pharmaceuticals in Colombia – pharmaceutical drug regulatory affairs Marketing Authorization Process for Pharmaceuticals in Colombia Step 1: Understanding the Regulatory Landscape in Colombia The first step in navigating the marketing authorization process for pharmaceuticals in Colombia is to gain a comprehensive understanding of the regulatory framework. The National Institute for Food and Drug Surveillance (INVIMA) is the primary regulatory body responsible for overseeing the approval of pharmaceutical products. Familiarity with INVIMA’s organizational structure, processes, and guidelines is essential for regulatory affairs professionals. In Colombia, the regulatory landscape is guided by several key legal and procedural documents,…

Requirements for CTD Submissions and Local Dossier Structure – regulatory affairs in pharma Requirements for CTD Submissions and Local Dossier Structure in Colombia (INVIMA) As the pharmaceutical landscape expands globally, regulatory affairs in pharma have become increasingly significant. For companies looking to market their products in Colombia, an understanding of the requirements for CTD submissions and the local dossier structure is essential. This article provides a comprehensive step-by-step guide to navigate these regulatory pathways for effective market authorization in Colombia. Step 1: Understanding the CTD Format The Common Technical Document (CTD) format is an internationally recognized standard designed to facilitate…

Clinical Trial Approval: National Bioethics and Regulatory Pathway – pharmaceutical regulatory affairs Clinical Trial Approval: National Bioethics and Regulatory Pathway Conducting clinical trials in Colombia requires navigating a complex landscape of regulations, ethics, and approval processes governed by INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos). This step-by-step guide aims to equip professionals in pharmaceutical regulatory affairs with a comprehensive roadmap for securing clinical trial approval in Colombia. Step 1: Understanding Regulatory Framework and Stakeholders Before initiating the clinical trial approval process in Colombia, it is imperative to understand the regulatory framework and key stakeholders involved. INVIMA is the…

Labeling and Patient Information Leaflet Guidelines in Colombia – pharmaceutical drug regulatory affairs Labeling and Patient Information Leaflet Guidelines in Colombia In the complex arena of pharmaceutical drug regulatory affairs, the preparation of labeling and patient information leaflets (PILs) in Colombia is a crucial step for achieving regulatory compliance. This guide outlines the comprehensive process to ensure that your pharmaceutical labeling meets the standards set by INVIMA, the Colombian National Institute for Food and Drug Monitoring. Step 1: Understanding the Regulatory Framework for Labeling in Colombia Before preparing labels and PILs, it is essential to understand the regulatory framework that…

GMP Certification and Site Audit Process by INVIMA – pharmaceutical regulatory affairs GMP Certification and Site Audit Process by INVIMA The process for obtaining Good Manufacturing Practice (GMP) certification and the accompanying site audit conducted by INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos) is a critical phase for pharmaceutical companies wishing to operate in Colombia or export to international markets. This step-by-step guide aims to provide a comprehensive understanding of the requirements and necessary actions, aligning with the best practices of pharmaceutical regulatory affairs. Step 1: Understanding GMP Certification Requirements Before embarking on the application process for GMP…

Pharmacovigilance Obligations and Risk Management Plans – drug regulatory affairs Pharmacovigilance Obligations and Risk Management Plans in Colombia – A Comprehensive Guide for Drug Regulatory Affairs Pharmacovigilance is an essential aspect of ensuring drug safety and effectiveness throughout the product life cycle. In Colombia, the regulatory framework for pharmacovigilance is governed by INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos), which outlines specific obligations for companies in the drug regulatory affairs landscape. This step-by-step guide aims to provide an in-depth understanding of the pharmacovigilance obligations and Risk Management Plans (RMPs) required by INVIMA for pharmaceutical companies operating in the…

Medical Device Registration Categories and Requirements – pharmaceutical drug regulatory affairs Medical Device Registration Categories and Requirements The process of registering medical devices in Colombia through the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) requires a comprehensive understanding of the regulatory framework governing pharmaceutical drug regulatory affairs. This article outlines the essential steps involved in obtaining market authorization for medical devices in Colombia, considering applicable regulations, documentation requirements, and processes established by INVIMA. Step 1: Understand the Regulatory Framework The first step in navigating the pharmaceutical drug regulatory affairs specific to medical devices in Colombia is to familiarize…

Approval Pathways for Biologics and Biosimilars – regulatory affairs in pharma Approval Pathways for Biologics and Biosimilars – regulatory affairs in pharma As the pharmaceutical landscape continues to evolve, understanding the approval pathways for biologics and biosimilars becomes increasingly essential for regulatory affairs professionals. This guide provides a comprehensive overview of the necessary steps involved in the regulatory affairs process, specifically focusing on Colombia’s regulatory authority, INVIMA. By following this step-by-step tutorial, professionals in the field of regulatory affairs in pharma will gain valuable insights into the processes, documentation, and regulatory expectations necessary for the successful approval of biologics and…

Nutritional Supplements and Herbal Products Registration – pharmaceutical regulatory affairs Nutritional Supplements and Herbal Products Registration – Pharmaceutical Regulatory Affairs In today’s globalized market, the registration of nutritional supplements and herbal products requires a thorough understanding of country-specific regulations. In Colombia, this process is governed by INVIMA (Instituto Nacional de Vigilancia de Medicamentos y Alimentos). This step-by-step guide provides essential insights into the regulatory framework necessary for the successful registration of these products. The focus will be on practical actions, documentation expectations, and adherence to best practices aligned with international guidelines. Step 1: Understanding the Regulatory Framework in Colombia The…